Pall Corporation, Inc., Eurofins Scientific and Lonza are Dominating the Asia-Pacific Endotoxin and Pyrogen Testing market in 2020

Asia-Pacific Endotoxin and Pyrogen Testing Market is expected to grow with the CAGR of 11.8% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/asia-pacific-endotoxin-and-pyrogen-testing-market

Asia-Pacific Endotoxin and Pyrogen Testing market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in Asia-Pacific Endotoxin and Pyrogen Testing market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced wound debridement device product portfolio. For instance, in December 2018, Pall Corporation (A Subsidiary of Danaher) established the Centre of Excellence (CoE) for biotech integrated solutions in Shanghai, China. This new excellence centre opened by the company, equipped with advanced equipment and platforms has increased the production capacity of the products leading to balance in meeting the demand of the people in the region.

Pall Corporation is the dominating player in Asia-Pacific Endotoxin and Pyrogen Testing market. The other key players existing in the market includes Eurofins Scientific, Thermo Fisher Scientific Inc., Lonza, Charles River Laboratories, Merck KGaA, STERIS plc, SGS SA, Sartorius AG, bioMérieux SA, Ellab A/S, Wako USA (A subsidiary of FUJIFILM Wako Pure Chemical Corporation), ASSOCIATES OF CAPE COD, INC., WuXi AppTec, Microcoat Biotechnologie GmbH, Sanquin, Reading Scientific Services Ltd, nanoComposix, Zwisler Laboratorium GmbH and GenScript, among others.

Pall Corporation (a subsidiary of Danaher)

Zio by iRhythm Technologies, Inc, has it base headquarters in New York, U.S. The company is focused on high-tech filtration, separation and purification solutions to meet critical fluid, management needs of a broad spectrum of life sciences and industrial sectors. The company deals in product categories which are biotech, food and beverage, laboratory, medical, aerospace, chemicals and polymers , industrial manufacturing, microelectronics , oil and gas, power generation out of which biotech and laboratory is the market focused market focused segment.

• In December 2018,  Pall Corporation (A Subsidiary of Danaher) established the Center of Excellence (CoE) for biotech integrated solutions in Shanghai, China. This new excellence centre opened by the company, equipped with advanced equipment and platforms has increased the production capacity of the products leading to balance in meeting the demand of the people in the region

The company has presence in Americas, Europe, Asia Pacific, Middle East and Africa.

Eurofins Scientific

Eurofins Scientific is headquartered in Val Flieuri, Luxembourg, and was founded in 1987. The company is engaged in food, environment, pharmaceutical and cosmetic products testing and in agrocscience CRO services along with the expertise in testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and for supooritng clinical studies. The company has service categories such as agroscience services, agro testing, bio pharma services, clinical diagnostics out of which biopharma services are the market focused category.  

• In March 2016, Eurofins Scientific acquired AMS Laboratories Pty Ltd., an Australia based independent supplier of analytical and cGMP Quality Control services for medical devices and biopharmaceutical products. This acquisition done by the company has strengthened the foothills of the company in biopharmaceutical products testing in Australia region.

The company has wide global presence across North America, South America, Europe, Middle East and Africa, and Asia-Pacific. The company has various subsidiaries which are Eurofins Biomnis  (Middle East and Africa), Eurofins Food Testing UK Limited(London), Bioaccess S.A, DiscoveRx (San Francisco ), Megalab SA (Madrid ) among others.

Lonza

Lonza is headquartered in Basel, Switzerland and was founded in year 1897 The company is engaged in offering solutions for integrated healthcare solutions and in pharma, biotech and nutrition along with specialty ingredients. The business segments are Pharma Biotech and Nutrition and Specialty Ingredient, out of which Pharma Biotech and Nutrition. The company offers wide range of product in various categories such as Pharma and Biotech, Capsule and Health      Ingredients, Microbial Control Solutions and Specialty Chemical Services out of which Pharma and Biotech is market focused category.     

• In October 2020,  Lonza unveiled its latest PyroCell MAT System to detect various pyrogens sensitively and sustainably, without the need for laboratory animals. The product was launched with a full solution with optimized MAT reagents from Sanquin and media and accessories from Lonza. The company's introduction of this new product has boosted its credibility and market demand.

The company has wide global presence across the world in Europe , America, Asia-Pacific , Middle East and Africa. The subsidiaries are Capsugel, (U.S.), Arch Chemicals, Inc. (U.S.), Lonza Walkersville, Inc. (U.S.), BacThera AG (Switzerland), Micro-Macinazione S.A.(Switzerland) among others.